Lunaphore is a start-up company, spin-off of EPFL, in the medtech field. We build tumor analysis and classification platforms based on a microfluidic technology.

With our platform, a test can be performed in less than 5min, v.s. 2-8h using other technologies. In addition, clinical trials have demonstrated 90% more accurate results when testing samples using our platform than with techniques currently used in hospitals.